These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16763797

  • 1. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group.
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [Abstract] [Full Text] [Related]

  • 2. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C, Gerss J, Sauerland C, Kampik A, Ulbig MW, CALDIRET study group.
    Lancet; 2009 Apr 18; 373(9672):1364-71. PubMed ID: 19376452
    [Abstract] [Full Text] [Related]

  • 3. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB, Mota MC, de Abreu JR, Cunha-Vaz JG.
    Int Ophthalmol; 1990 Mar 18; 14(2):81-8. PubMed ID: 2187006
    [Abstract] [Full Text] [Related]

  • 4. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV.
    Vestn Oftalmol; 2016 Mar 18; 132(5):60-67. PubMed ID: 27911427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P, Farine JC, Barras JP.
    Int J Clin Pract; 1999 Dec 18; 53(8):631-6. PubMed ID: 10692760
    [Abstract] [Full Text] [Related]

  • 7. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
    Javadzadeh A, Ghorbanihaghjo A, Adl FH, Andalib D, Khojasteh-Jafari H, Ghabili K.
    Mol Vis; 2013 Dec 18; 19():62-8. PubMed ID: 23335852
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
    Schalnus R, Ohrloff C.
    Ophthalmic Res; 1995 Dec 18; 27 Suppl 1():116-23. PubMed ID: 8577448
    [Abstract] [Full Text] [Related]

  • 10. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
    Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG.
    Arch Ophthalmol; 2004 Feb 18; 122(2):211-7. PubMed ID: 14769598
    [Abstract] [Full Text] [Related]

  • 11. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL, Smith ME, Aronson SB, Cavender JC, Cleasby GW, Fung WE, Becker B.
    Ophthalmology; 1978 Jun 18; 85(6):594-606. PubMed ID: 353623
    [Abstract] [Full Text] [Related]

  • 12. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B, Thornit DN, Colmorn L, Strøm C, Girach A, Hubbard LD, Lund-Andersen H, Larsen M.
    Invest Ophthalmol Vis Sci; 2007 Sep 18; 48(9):3983-7. PubMed ID: 17724176
    [Abstract] [Full Text] [Related]

  • 13. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW, Sander E, Hoppe R.
    Diabetologia; 1977 Apr 18; 13(2):105-9. PubMed ID: 323093
    [Abstract] [Full Text] [Related]

  • 14. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
    Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA.
    Ophthalmic Res; 1985 Apr 18; 17(3):131-8. PubMed ID: 4011126
    [Abstract] [Full Text] [Related]

  • 15. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C, Koerner F.
    Ophthalmologica; 1985 Apr 18; 190(2):102-11. PubMed ID: 3982791
    [Abstract] [Full Text] [Related]

  • 16. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
    Salama Benarroch I, Nano H, Pérez H, Elizalde F, Bisceglia H, Salama A.
    Ophthalmologica; 1977 Apr 18; 174(1):47-51. PubMed ID: 322009
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
    Hu H, Liu J, Wang D, Qiu S, Yuan Y, Wang F, Wen L, Song Q, Sun ZL.
    BMJ Open; 2021 May 28; 11(5):e045256. PubMed ID: 34049911
    [Abstract] [Full Text] [Related]

  • 18. Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study.
    Cunha-Vaz J, Lobo C, Sousa JC, Oliveiros B, Leite E, de Abreu JR.
    Graefes Arch Clin Exp Ophthalmol; 1998 Apr 28; 236(4):264-8. PubMed ID: 9561358
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.
    Castillo A, Benitez del Castillo JM, Diaz D, Sayagues O, Ruibal JL, Garcia-Sanchez J.
    Graefes Arch Clin Exp Ophthalmol; 1996 Apr 28; 234(4):246-50. PubMed ID: 8964530
    [Abstract] [Full Text] [Related]

  • 20. Prevention of diabetic retinopathy.
    Einarsdóttir AB, Stefánsson E.
    Lancet; 2009 Apr 18; 373(9672):1316-8. PubMed ID: 19376433
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.